Editorial: Characterization of biotherapeutic products

被引：0
|
作者：
Rathore, Anurag S. [1 ]
Smales, C. Mark [2 ]
Guttman, Andras [3 ]
机构：
[1] Indian Inst Technol Delhi, New Delhi, India
[2] Univ Kent, Sch Biosci, Div Nat Sci, Canterbury, Kent, England
[3] Univ Debrecen, Fac Med, Res Ctr Mol Med, Doctoral Sch Mol Med,Horvath Csaba Mem Lab Biosep, Debrecen, Hungary
来源：
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY | 2022年 / 10卷
关键词：
biotherapeutics; analytical characterisation; biosimilarity assessment; critical quality attributes (CQAs); post translational modifications (PTMs); virus like particles (VLPs);
D O I：
10.3389/fbioe.2022.993262
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Live biotherapeutic products: the importance of a defined regulatory framework
    Magali Cordaillat-Simmons
    Alice Rouanet
    Bruno Pot
    Experimental & Molecular Medicine, 2020, 52 : 1397 - 1406
  • [22] Factors that influence clinical efficacy of live biotherapeutic products
    Pot, Bruno
    Vandenplas, Yvan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2021, 26 (01)
  • [23] Live biotherapeutic products and their regulatory framework in Italy and Europe
    Franciosa, Giovanna
    Guida, Serena
    Miguel, Maria Jesus Gomez
    Von Hunolstein, Christina
    ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2023, 59 (01): : 56 - 67
  • [24] Live Biotherapeutic Products, A Road Map for Safety Assessment
    Rouanet, Alice
    Bolca, Selin
    Bru, Audrey
    Claes, Ingmar
    Cvejic, Helene
    Girgis, Haymen
    Harper, Ashton
    Lavergne, Sidonie N.
    Mathys, Sophie
    Pane, Marco
    Pot, Bruno
    Shortt, Colette
    Alkema, Wynand
    Bezulowsky, Constance
    Blanquet-Diot, Stephanie
    Chassard, Christophe
    Claus, Sandrine P.
    Hadida, Benjamin
    Hemmingsen, Charlotte
    Jeune, Cyrille
    Lindman, Bjorn
    Midzi, Garikai
    Mogna, Luca
    Movitz, Charlotta
    Nasir, Nail
    Oberreither, Manfred
    Seegers, Jos F. M. L.
    Sterkman, Luc
    Valo, Audrey
    Vieville, Frederique
    Cordaillat-Simmons, Magali
    FRONTIERS IN MEDICINE, 2020, 7
  • [25] Live biotherapeutic products: the importance of a defined regulatory framework
    Cordaillat-Simmons, Magali
    Rouanet, Alice
    Pot, Bruno
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (09): : 1397 - 1406
  • [26] PAT informing the manufacture and formulation of biotherapeutic protein products
    Moore-Kelly, C.
    Welsh, J.
    Thomas, O. R. T.
    Dafforn, T. R.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2015, 44 : S207 - S207
  • [27] Discovery and delivery strategies for engineered live biotherapeutic products
    Heavey, Mairead K.
    Durmusoglu, Deniz
    Crook, Nathan
    Anselmo, Aaron C.
    TRENDS IN BIOTECHNOLOGY, 2022, 40 (03) : 354 - 369
  • [28] Factors that influence clinical efficacy of live biotherapeutic products
    Bruno Pot
    Yvan Vandenplas
    European Journal of Medical Research, 26
  • [29] Development of novel methods for periplasmic release of biotherapeutic products
    Kraemer, J.
    Harris, C.
    Ali, A.
    Ruder, L. R.
    Davies, R.
    Thomas, O. R. T.
    Dafforn, T. R.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2015, 44 : S126 - S126
  • [30] Microbiological insights and dermatological applications of live biotherapeutic products
    Locker, Jessica
    Serrage, Hannah J.
    Ledder, Ruth G.
    Deshmukh, Shivprasad
    O'Neill, Catherine A.
    Mcbain, Andrew J.
    JOURNAL OF APPLIED MICROBIOLOGY, 2024, 135 (08)
12345